Projects funded by the NCN
Radiopharmaceuticals based on neurokinin-1 receptor antagonists for the diagnosis and therapy of a brain tumour - glioblastoma multiforme.
2017/25/B/NZ7/01896
Keywords:
glioblastoma multiforme aprepitant radiopharmaceuticals NK-1 rceptor NK1 receptor antagonists
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST5_16:
- ST4_16: Ionic liquids
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk
woj. mazowieckie
Principal investigator (from the host institution):
prof. Aleksandra Misicka-Kęsik
Number of co-investigators in the project: 9
Call: OPUS 13 - announced on 2017-03-15
Amount awarded: 961 230 PLN
Project start date (Y-m-d): 2018-02-15
Project end date (Y-m-d): 2022-02-14
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.